inTEST Q1 revenue up 23% YoY to $24.1M; GAAP EPS $0.05, non-GAAP EPS $0.12

INTEST CORP

2022-Q1 EPS reported $0.05 revenue$24,081,000

Revenue $24.1M (+23% YoY, +8% sequential); GAAP diluted EPS $0.05; non-GAAP diluted EPS $0.12 in line with guidance.
Orders of $25.1M in Q1; record quarter-end backlog of $35.0M demonstrates strong demand.
Acquisitions (North Sciences, Videology, Acculogic) integrations on track; segment reorganization into three divisions.
Gross margin 45.7% down from 48.7% a year ago; operating margin 3.2% vs 13.1% due to higher S&A and amortization.
Full-year 2022 outlook maintained; supply chain constraints persist but end-market demand healthy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.